Literature DB >> 15157948

Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome.

Leslie J Crofford1, Elizabeth A Young, N Cary Engleberg, Ania Korszun, Christine B Brucksch, Leslie A McClure, Morton B Brown, Mark A Demitrack.   

Abstract

The objective of this study was to evaluate and compare the basal circadian and pulsatile architecture of the HPA axis in groups of patients with FMS, CFS, or both syndromes with individually matched control groups. Forty patients with either FMS (n = 13), FMS and CFS (n = 12), or CFS (n = 15) were matched by age (18-65), sex, and menstrual status to healthy controls. Subjects were excluded if they met criteria for major Axis I psychiatric disorders by structured clinical interview (SCID). Subjects were admitted to the General Clinical Research Center where meals and activities were standardized. Blood was collected from an intravenous line every 10 min over 24 h for analysis of ACTH and cortisol. Samples were evaluable for ACTH in 36 subject pairs and for cortisol in 37 subject pairs. There was a significant delay in the rate of decline from acrophase to nadir for cortisol levels in patients with FMS (P <.01). Elevation of cortisol in the late evening quiescent period was evident in half of the FMS patients compared with their control group, while cortisol levels were numerically, but not significantly, lower in the overnight period in patients with CFS compared with their control group. Pulsatility analyses did not reveal statistically significant differences between patient and control groups. We conclude that the pattern of differences for basal circadian architecture of HPA axis hormones differs between patients with FMS and CFS compared to their matched control groups. The abnormalities in FMS patients are consistent with loss of HPA axis resiliency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157948     DOI: 10.1016/j.bbi.2003.12.011

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  62 in total

Review 1.  Modeling the hypothalamus-pituitary-adrenal axis: A review and extension.

Authors:  Niyousha Hosseinichimeh; Hazhir Rahmandad; Andrea K Wittenborn
Journal:  Math Biosci       Date:  2015-08-12       Impact factor: 2.144

Review 2.  Endocrinology: the active partner in PNI research.

Authors:  William B Malarkey; Paul J Mills
Journal:  Brain Behav Immun       Date:  2006-12-15       Impact factor: 7.217

3.  Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder.

Authors:  Kathleen C Light; Edith E Bragdon; Karen M Grewen; Kimberly A Brownley; Susan S Girdler; William Maixner
Journal:  J Pain       Date:  2009-05       Impact factor: 5.820

4.  Modeling diurnal hormone profiles by hierarchical state space models.

Authors:  Ziyue Liu; Wensheng Guo
Journal:  Stat Med       Date:  2015-07-07       Impact factor: 2.373

5.  [Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain].

Authors:  C Sommer; W Häuser; K Gerhold; P Joraschky; F Petzke; T Tölle; N Uçeyler; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 6.  Is chronic fatigue syndrome the same illness as fibromyalgia: evaluating the 'single syndrome' hypothesis.

Authors:  B Abbi; B H Natelson
Journal:  QJM       Date:  2012-08-26

Review 7.  Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome.

Authors:  Andrew S Papadopoulos; Anthony J Cleare
Journal:  Nat Rev Endocrinol       Date:  2011-09-27       Impact factor: 43.330

Review 8.  Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.

Authors:  Kevin G Burfeind; Vijayshree Yadav; Daniel L Marks
Journal:  Curr Neurol Neurosci Rep       Date:  2016-11       Impact factor: 5.081

9.  Atypical depression is more common than melancholic in fibromyalgia: an observational cohort study.

Authors:  Rebecca L Ross; Kim D Jones; Rachel L Ward; Lisa J Wood; Robert M Bennett
Journal:  BMC Musculoskelet Disord       Date:  2010-06-14       Impact factor: 2.362

10.  Model-based therapeutic correction of hypothalamic-pituitary-adrenal axis dysfunction.

Authors:  Amos Ben-Zvi; Suzanne D Vernon; Gordon Broderick
Journal:  PLoS Comput Biol       Date:  2009-01-23       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.